Literature DB >> 23811816

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit.

N Lehners1, P Schnitzler, S Geis, J Puthenparambil, M A Benz, B Alber, T Luft, P Dreger, C Eisenbach, C Kunz, A Benner, U Buchholz, E Aichinger, U Frank, K Heeg, A D Ho, G Egerer.   

Abstract

Respiratory syncytial virus (RSV) usually causes self-limiting upper respiratory tract infections, but can be associated with severe lower respiratory tract infection disease (LRTID) in infants and in patients with hematologic malignancies. We have analyzed the risk factors and the measures for containment within an outbreak of nosocomial RSV infections in a hematology and SCT unit. A total of 56 patients were affected (53 RSV-A and 3 RSV-B) including 32 transplant patients (16 allogeneic and 16 autologous). Forty (71%) of the 56 patients suffered from LRTID and 14 (35%) of the patients with LRTID subsequently died. However, because of concomitant infections with fungal and bacterial pathogens, the impact of RSV on the fatal outcome was difficult to assess. Multivariate analysis showed that low levels of IgG were significantly associated with fatal outcome (P=0.007), treatment with oral ribavirin represented a protective factor (P=0.02). An extremely protracted viral shedding was observed in this cohort of patients (median=30.5 days, range: 1-162 days), especially pronounced in patients after allogeneic transplantation (P=0.002). Implementation of rigorous isolation and barrier measures, although challenged by long-term viral carriers, was effective in containment of the outbreak.

Entities:  

Mesh:

Year:  2013        PMID: 23811816     DOI: 10.1038/bmt.2013.94

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  28 in total

1.  [Acute dyspnea, subfebrile temperatures and chills in a patient with multiple myeloma].

Authors:  M Merz; I Herth; J Brandt; M Hundemer; K Neben; H Goldschmidt; C P Heußel
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10-23       Impact factor: 0.840

2.  Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.

Authors:  Kari Neemann; Alison Freifeld
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

Review 3.  Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.

Authors:  Sofia Tejada; Raquel Martinez-Reviejo; Hanife N Karakoc; Yolanda Peña-López; Oriol Manuel; Jordi Rello
Journal:  Adv Ther       Date:  2022-07-25       Impact factor: 4.070

4.  Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients.

Authors:  Claas Baier; Jiabin Huang; Kerstin Reumann; Daniela Indenbirken; Felicitas Thol; Christian Koenecke; Ella Ebadi; Albert Heim; Franz-Christoph Bange; Sibylle Haid; Thomas Pietschmann; Nicole Fischer
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-21       Impact factor: 6.454

5.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

6.  Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.

Authors:  Nicola Lehners; Julia Tabatabai; Christiane Prifert; Marianne Wedde; Joe Puthenparambil; Benedikt Weissbrich; Barbara Biere; Brunhilde Schweiger; Gerlinde Egerer; Paul Schnitzler
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

7.  Screening for respiratory syncytial virus and isolation strategies in children hospitalized with acute respiratory tract infection.

Authors:  Johannes Pfeil; Julia Tabatabai; Anja Sander; Markus Ries; Jürgen Grulich-Henn; Paul Schnitzler
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

8.  Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Authors:  Anne-Gaëlle Goubet; Agathe Dubuisson; Laurence Zitvogel; Lisa Derosa; Arthur Geraud; François-Xavier Danlos; Safae Terrisse; Carolina Alves Costa Silva; Damien Drubay; Lea Touri; Marion Picard; Marine Mazzenga; Aymeric Silvin; Garett Dunsmore; Yacine Haddad; Eugenie Pizzato; Pierre Ly; Caroline Flament; Cléa Melenotte; Eric Solary; Michaela Fontenay; Gabriel Garcia; Corinne Balleyguier; Nathalie Lassau; Markus Maeurer; Claudia Grajeda-Iglesias; Nitharsshini Nirmalathasan; Fanny Aprahamian; Sylvère Durand; Oliver Kepp; Gladys Ferrere; Cassandra Thelemaque; Imran Lahmar; Jean-Eudes Fahrner; Lydia Meziani; Abdelhakim Ahmed-Belkacem; Nadia Saïdani; Bernard La Scola; Didier Raoult; Stéphanie Gentile; Sébastien Cortaredona; Giuseppe Ippolito; Benjamin Lelouvier; Alain Roulet; Fabrice Andre; Fabrice Barlesi; Jean-Charles Soria; Caroline Pradon; Emmanuelle Gallois; Fanny Pommeret; Emeline Colomba; Florent Ginhoux; Suzanne Kazandjian; Arielle Elkrief; Bertrand Routy; Makoto Miyara; Guy Gorochov; Eric Deutsch; Laurence Albiges; Annabelle Stoclin; Bertrand Gachot; Anne Florin; Mansouria Merad; Florian Scotte; Souad Assaad; Guido Kroemer; Jean-Yves Blay; Aurélien Marabelle; Frank Griscelli
Journal:  Cell Death Differ       Date:  2021-07-06       Impact factor: 15.828

Review 9.  Antiviral T-cell therapy.

Authors:  Ann M Leen; Helen E Heslop; Malcolm K Brenner
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Authors:  Andrew J Ullmann; Martin Schmidt-Hieber; Hartmut Bertz; Werner J Heinz; Michael Kiehl; William Krüger; Sabine Mousset; Stefan Neuburger; Silke Neumann; Olaf Penack; Gerda Silling; Jörg Janne Vehreschild; Hermann Einsele; Georg Maschmeyer
Journal:  Ann Hematol       Date:  2016-06-24       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.